Last reviewed · How we verify

NCT05539742

Comparison of the Effect of MCFA and LCFA on Postprandial Appetite and Lipemia

Completed NA Last updated 29 August 2023
What this trial tests

NA trial testing Coconut oil in Lipemia in 26 participants. Completed in 1 November 2022.

Timeline
1 June 2022
Primary endpoint
1 October 2022
1 November 2022

Quick facts

Lead sponsorUniversity of Jordan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment26
Start date1 June 2022
Primary completion1 October 2022
Estimated completion1 November 2022
Sites2 locations across Jordan

Drugs / interventions tested

Conditions studied

Sponsor

University of Jordan

Who can join

Adults 18 to 40, any sex, with Lipemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective is to investigate if foods high in coconut oil (MCFA) or palm oil (LCFA) have different impacts on postprandial blood lipid levels and appetite via a visual analog scale (VAS).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of the effect of medium-chain fatty acids and long-chain fatty acids on postprandial appetite and lipemia: a randomised crossover trial.
    Jadallah R, Hammad SS. · · 2024 · cited 2× · PMID 39882282 · DOI 10.1136/bmjnph-2024-001029

Verify or expand the search:

Other trials of Coconut oil

Trials testing the same drug.

Other University of Jordan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05539742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing